Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Simple item page
dc.contributor.authorAmin, Asim
dc.contributor.authorPlimack, Elizabeth R
dc.contributor.authorErnstoff, Marc S
dc.contributor.authorLewis, Lionel D
dc.contributor.authorBauer, Todd M
dc.contributor.authorMcDermott, David F
dc.contributor.authorCarducci, Michael
dc.contributor.authorKollmannsberger, Christian
dc.contributor.authorRini, Brian I
dc.contributor.authorHeng, Daniel Y C
dc.contributor.authorKnox, Jennifer
dc.contributor.authorVoss, Martin H
dc.contributor.authorSpratlin, Jennifer
dc.contributor.authorBerghorn, Elmer
dc.contributor.authorYang, Lingfeng
dc.contributor.authorHammers, Hans J
dc.date.accessioned2019-03-17T02:24:53Z
dc.date.available2019-03-17T02:24:53Z
dc.date.issued2019-03-14
dc.date.updated2019-03-17T02:24:52Z
dc.description.abstract.
dc.identifier.citationJournal for ImmunoTherapy of Cancer. 2019 Mar 14;7(1):73
dc.identifier.doihttps://doi.org/10.1186/s40425-019-0559-3
dc.identifier.urihttp://hdl.handle.net/1880/110080
dc.identifier.urihttps://doi.org/10.11575/PRISM/44802
dc.language.rfc3066en
dc.rights.holderThe Author(s).
dc.titleCorrection to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
dc.typeunknown
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
40425_2019_Article_559.pdf
Size:
249.87 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications